FDA recall, , Moderate risk
Skin Script Blemish Spot Treatment
Blemish Spot Treatment failed stability specifications.
Summary by Recall Canary from the FDA notice
What happened
Island Kinetics, Inc. d.b.a. CoValence Laboratories, of Chandler, Arizona, recalled 28,163 bottles of Skin Script Blemish Spot Treatment (Salicylic Acid) 1%, .5 fl oz (15 ml) bottles, because the product failed stability specifications. The FDA added the recall to its Enforcement Report on April 16, 2026, and classified it on April 22, 2026. The product was distributed nationwide in the U.S.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is your bottle affected?
Match the UPC and lot code listed under your product.
A UPC is the number printed under a barcode.
Blemish Spot Treatment (Salicylic Acid) 1%, .5 fl oz (15 ml) bottles
- UPC
- 6 10563 13873 9
- Lot code
- 4228D2
- 4229D1
- 5147D2
Recall details
- Company began the recall
- Sold in
U.S. Nationwide
- Company
- Island Kinetics, Inc. d.b.a. CoValence LaboratoriesChandler, Arizona
- Hazard
- Quality testing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98705
- Recall number
- D-0487-2026
- Quantity recalled
- 28,163 bottles
All recalls from Island Kinetics, Inc. d.b.a. CoValence Laboratories
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report
Classified by FDA · In FDA's weekly enforcement report
Listed on Recall Canary
Summary updated
